Skip to main content

Binder Gwendolyn's Form 4 filing

Cabaletta Bio, Inc. (CABA) · filed May 19, 2023

Accession no.
0000899243-23-013455
Filed
May 19, 2023
Trade date
May 19, 2023
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $259.8K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Binder GwendolynCIK 0001791742Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 19, 2023Common StockMOption exerciseAcquired+22,000$1.01+$22,22042,000Direct
May 19, 2023Common StockSSaleDisposed−22,000$11.81−$259,82020,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 19, 2023Common StockMOption exerciseDisposed−22,000$0.00$0188,756Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)